GENEVA, May 18 -- NOVO NORDISK A/S (Novo Alle 12880 Bagsvaerd) filed a patent application (PCT/EP2025/081744) for "SEMAGLUTIDE IN THE TREATMENT OF INTERMITTENT CLAUDICATION" on Nov 04, 2025. With publication no. WO/2026/099147, the details related to the patent application was published on May 15, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CATARIG, Andrei-Mircea (Novo Alle 12880 Bagsvaerd), ROPCKE, Diana, Mathilde (Novo Alle 12880 Bagsvaerd), HOLST, Anders, Gaarsdal (Novo Alle 12880 Bagsvaerd)
Abstract: Disclosed herein is a further medical use of semaglutide, namely semaglutide in the...